Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
---|
01/05/2005 | EP1027349B1 Tetrahydrofuran phosphate- and hydroxy esters, as prodrugs for the corresponding antifungal agent |
01/05/2005 | EP1006110B8 Derivatives of acyl-piperazinil-pyrimidins, preparation thereof and application as medicaments |
01/05/2005 | DE10326940A1 Indol-Derivate Indole derivatives |
01/05/2005 | DE10326939A1 Indol-Derivate Indole derivatives |
01/05/2005 | CN1561393A Inhibitors of glycogen synthase kinase-3 (GSK-3) for treating glaucoma |
01/05/2005 | CN1561341A Hydrolysis of [R(R*, R*)]-2-(4-fluorophenyl)-beta, delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino) carbonyl]-1H-pyrrole-1-heptanoic acid esters with calcium hydroxide |
01/05/2005 | CN1561338A Chroman derivatives as 5-hydroxytryptamine-6 ligands |
01/05/2005 | CN1561211A Nociceptin analogs |
01/05/2005 | CN1560051A 取代吡唑化合物 A substituted pyrazole compound |
01/05/2005 | CN1560041A Compounds and methods for treatment of asthma, allergy and inflammatory disorders |
01/05/2005 | CN1183116C Substituted isoquinoline derivatives and pharmaceutical composition containing them, its preparation method and use |
01/05/2005 | CN1183113C Tri-aryl acid derivatives as PPAR receptor ligands |
01/05/2005 | CN1182782C Synergistic herbicidal composition and method for preventing and control of weeds |
01/05/2005 | CN1182781C Synergistic herbicidal composition and method for preventing and control of weeds |
01/04/2005 | US6838564 Substituted pyridine herbicides |
01/04/2005 | US6838483 Sulfonated amino acid derivatives and metalloproteinase inhibitors containing the same |
01/04/2005 | US6838478 Use as anticoagulants; competitive inhibitors of thrombin; for example, 1-(phenyl-2-hydroxyethane-1,1-diylcarbonyl), 2-((4-amidinophenyl)-alkylaminocarbonyl)azetidine |
01/04/2005 | US6838474 Prodrugs of a class of sulfonamides which are aspartyl protease inhibitors. This invention relates to a novel class of prodrugs of HIV aspartyl protease inhibitors characterized by favorable aqueous solubility, high oral bioavailability and |
01/04/2005 | US6838468 4-(phenyl-piperdin-4-ylidene methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
01/04/2005 | US6838465 N-acyltetrahydroisoquinoline derivatives |
01/04/2005 | US6838128 Comprises chiral, nonracemic gamma-lactone tail |
01/04/2005 | CA2350854C 1,4-dihydropyridine derivatives and methods of producing the same |
01/04/2005 | CA2293834C Substituted naphthopyrans |
01/04/2005 | CA2186015C Nicotinic acid derivatives and herbicides |
01/04/2005 | CA2124696C Vasopressin antagonist and oxytocin antagonist |
12/30/2004 | US20040267024 Nitrogen compounds, formed by condensing carbocyclic, hydroxy ethers such as 3-(2',4'-difluorophenyl)-3,4-epoxy-2-butanol, with 1,2,4-triazole in the presence of bases; fungicides |
12/30/2004 | US20040267016 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially ccr5) |
12/30/2004 | US20040267013 long-wave absorption maxima in the open form thereof; enables violet to blue tints to be obtained when used in photochromic articles; ophthalmic lenses |
12/30/2004 | US20040267008 Cyclization of (2-Oxo-4-(2-oxo-2-(tetrahydrofuran-2-yl)-ethylsulfanyl)-3-phenylacetylamino -azetidin-1-yl)-(trimethyl- alpha -phosphanylidene)-acetic acid 4-nitro-benzyl ester; reacting with acid |
12/30/2004 | US20040266856 Biaryloxymethylarenecarboxylic acids as glycogen synthase activator |
12/30/2004 | US20040266825 Using impurity as marker for stability of paroxetine hydrochloride; quantitative analysis |
12/30/2004 | US20040266823 Such as N-[1-(3-phenyl-3-benzoylamino]propyl)-4-piperidinyl]-N-ethylmethanesulfonylphenylacetamide; autoimmune and inflammatory diseases; rheumatoid arthritis; synthesis |
12/30/2004 | US20040266820 quinolin-2-ones and chromen-2-ones compounds that have been derivatized at the 6-position with a urea or thiourea derivative; used as androgen antagonists; kits |
12/30/2004 | US20040266817 3-Substituted 6,7-dihydroxytetrahydroisoquinoline derivatives for use as antibacterial agents |
12/30/2004 | US20040266789 Substituted amino carboxylic acids |
12/30/2004 | US20040266788 treatment of diabetes and/or cancer; useful in the treatment of syndrome X; capable of inhibiting Protein tyrosine phosphatase |
12/30/2004 | US20040266770 treating diseases that are triggered by persistent angiogenesis; inhibition of the VEGF receptor |
12/30/2004 | US20040266764 Hydroxamic acid derivatives |
12/30/2004 | US20040266759 Possess antithrombotic and anticoagulant properties; example compound: 1-(5-Chlorobenzo[b]furan-2-ylsulphonyl)-4-[4-(4-pyridyl)benzoyl]piperazine |
12/30/2004 | US20040265979 Novel macrophage foam cell formation inhibitor fka-25 and process for producing the same |
12/30/2004 | DE10326386A1 N-Heterocyclyl-phenylsubstituierte cyclische Ketoenole N-heterocyclyl-substituted cyclic ketoenols |
12/29/2004 | WO2004113357A2 Nucleoside analog inhibitors of reverse transcriptase |
12/29/2004 | WO2004113327A1 Epoxy compound and cured epoxy resin product |
12/29/2004 | WO2004113326A1 Indole derivatives as serotonin reuptake inhibitors |
12/29/2004 | WO2004113325A1 Indole derivative in the form of serotonin reabsorbing inhibitors |
12/29/2004 | WO2004113322A1 Processes for the preparation of 1-[(benzoimidazole-1yl) quinolin-8-yl] piperidin-4-ylamine derivatives |
12/29/2004 | WO2004113320A1 Cannabinoid derivatives, methods of making, and use thereof |
12/29/2004 | WO2004113316A1 Benzofuran inhibitors of factor viia |
12/29/2004 | WO2004113303A1 INDAZOLE/PYRZOLO[4,3-c]PYRIDIN DERIVATIVES AS JNK INHIBITORS, COMPOSITIONS AND METHODS RELATED THERETO AS WELL AS INTERMEDIATE THEREOF |
12/29/2004 | WO2004113296A1 A process for preparation of 1-[9h-carbazol-4-yloxy]- 3-[{2-(2-(-(methoxy)phenoxy)-ethyl}-amino]-propan-2-ol |
12/29/2004 | WO2004113290A1 Substituted alkylamides |
12/29/2004 | WO2004113286A2 Mucin synthesis inhibitors |
12/29/2004 | WO2004112793A1 Guanidino-substituted quinazolinone compounds as mc4-r agonists |
12/29/2004 | WO2004112791A1 Therapeutic and/or preventive agent for lung disease |
12/29/2004 | WO2004112719A2 Chemical compounds |
12/29/2004 | WO2004076412A3 Aminoheteroaryl compounds as protein kinase inhibitors |
12/29/2004 | EP1491590A1 Triphenylmethane colorant compounds |
12/29/2004 | EP1491541A1 Pyridazinone aldose reductase inhibitors |
12/29/2004 | EP1491540A1 Pyridazinone aldose reductase inhibitors |
12/29/2004 | EP1491533A2 Quinoline-and naphthalenecarboxamides, pharmaceutical compositions thereof and their use as calpain inhibitors |
12/29/2004 | EP1491532A1 Heteroaryl diazacycloalkanes as cholinergic ligands at nicotinic acetyloholine receptors |
12/29/2004 | EP1490384A2 A building block forming a c-c bond upon reaction |
12/29/2004 | EP1490357A1 Stable hydrate of a muscarinic receptor antagonist |
12/29/2004 | EP1490356A1 (3z)-3-(3-hydro-isobenzofuran-1-ylidene)-1,3-dihydro-2h-indol-2-ones as kinase inhibitors |
12/29/2004 | EP1490354A1 4-imidazolyl substituted pyrimidine derivatives with cdk inhibitory activity |
12/29/2004 | EP1490350A1 Pyranon and pyrandion inhibitors of hepatitis c virus rna-dependent rna polymerase |
12/29/2004 | EP1490349A1 Therapeutic ion channel blocking agents and methods of use thereof |
12/29/2004 | EP1490343A1 New aryl imidazoles and related compounds as c5a receptor modulators |
12/29/2004 | EP1490341A1 Novel adamantane derivatives |
12/29/2004 | EP1490340A1 Heteroaromatic urea derivatives as vr-1 receptor modulators for treating pain |
12/29/2004 | EP1490339A1 Novel chalcone derivatives and uses thereof |
12/29/2004 | EP1490334A1 Phthalimido derivatives as inhibitors of monoamine oxidase b |
12/29/2004 | EP1490064A1 Substituted pyridinones as modulators of p38 map kinase |
12/29/2004 | EP1490062A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
12/29/2004 | EP1490061A1 Pharmaceutical compositions comprising a benzofuran derivative and their use for the treatment of attention deficit/hyperactivity disorder |
12/29/2004 | EP1414800B1 A novel synthesis for heteroarylamine compounds |
12/29/2004 | EP1373259B1 Pyridazinone aldose reductase inhibitors |
12/29/2004 | EP1233769A4 Novel compounds |
12/29/2004 | EP1230224B1 Substituted 5-benzyl-2,4-diaminopyrimidines |
12/29/2004 | EP1226138B1 Fab i inhibitors |
12/29/2004 | EP1226136B1 Tyrosine kinase inhibitors |
12/29/2004 | EP1216234B1 Mediators of hedgehog signaling pathways, compositions and uses related thereto |
12/29/2004 | EP1177178B1 Heterocyclically substituted benzimidazoles, the production and application thereof |
12/29/2004 | EP1176140B1 Amide compounds and medicinal use thereof |
12/29/2004 | EP1056729B1 N-[(substituted five-membered di- or triaza diunsaturated ring)carbonyl]guanidine derivatives for the treatment of ischemia |
12/29/2004 | EP0934303B1 Compounds useful for inhibition of farnesyl protein transferase |
12/29/2004 | EP0929545B1 Tricyclic inhibitors of farnesyl protein transferase |
12/29/2004 | CN1558904A Substituted alkylaminopyridazinone derivatives, process for the preparation thereof and pharmaceutical composition containing the same |
12/29/2004 | CN1558898A Antiviral agent |
12/29/2004 | CN1558761A Substituted benzimidazole compounds and their use for the treatment of cancer |
12/29/2004 | CN1558759A 病毒聚合酶抑制剂 Viral polymerase inhibitors |
12/29/2004 | CN1558758A Novel pyrroles having hypolipidemic hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them and their use in medicine |
12/29/2004 | CN1558719A Nicotinic acid-heterocyclyl-amides and analogous pyrimidine derivatives serving as pesticides |
12/29/2004 | CN1182134C Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for treatment of pain |
12/29/2004 | CN1182129C Benzopyran derivatives having leukotriene-antagonistic action |
12/29/2004 | CN1182123C Substituted bicyclic derivatives useful as anticancer agents |
12/29/2004 | CN1182114C Piperazine derivatives used as CCR5 antagonist |
12/29/2004 | CA2530058A1 Mucin synthesis inhibitors |
12/29/2004 | CA2529298A1 Indole derivatives as serotonin reuptake inhibitors |
12/29/2004 | CA2526103A1 Cannabinoid derivatives, methods of making, and use thereof |